The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - ARIAD; Bristol-Myers Squibb; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Five-year results of the ponatinib phase II PACE trial in heavily pretreated CP-CML patients (pts).
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Javier Pinilla-Ibarz
Honoraria - ARIAD; Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - ARIAD; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Pfizer
 
Philipp D. Le Coutre
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
 
Ronald Paquette
Speakers' Bureau - ARIAD; Bristol-Myers Squibb
 
Charles Chuah
Honoraria - Avillion; Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Franck E. Nicolini
No Relationships to Disclose
 
Jane Apperley
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Incyte; Novartis; Pfizer; Sun Pharma
Speakers' Bureau - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - ARIAD; Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
Hanna Jean Khoury
Consulting or Advisory Role - ARIAD; AstraZeneca; Bristol-Myers Squibb; Pfizer; Teva
 
Moshe Talpaz
Consulting or Advisory Role - Pfizer
Research Funding - ARIAD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - ARIAD; Pfizer
 
Michele Baccarani
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - ARIAD
Speakers' Bureau - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - ARIAD; Novartis
 
Stephanie Lustgarten
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Sergio Santillana
Employment - ARIAD; Takeda
Leadership - ARIAD
Stock and Other Ownership Interests - ARIAD; Takeda
Patents, Royalties, Other Intellectual Property - Patent related to work in Takeda (2015-2016) submitted for approval
Travel, Accommodations, Expenses - ARIAD; Takeda
 
Francois Guilhot
Honoraria - ARIAD
Consulting or Advisory Role - Celgene; Novartis
 
Michael W.N. Deininger
Honoraria - ARIAD; Bristol-Myers Squibb; CTI; Galena Biopharma; Incyte; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; CTI; Incyte; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst)
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - ARIAD; CTI; CTI; Galena Biopharma; Novartis; Pfizer
 
Andreas Hochhaus
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Timothy P. Hughes
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - ARIAD (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
 
Neil P. Shah
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Pfizer (Inst); Plexxikon (Inst)
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; ARIAD; BiolineRx; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Teva (Inst)